X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3574) 3574
Publication (472) 472
Book Review (84) 84
Book Chapter (29) 29
Dissertation (17) 17
Book / eBook (12) 12
Conference Proceeding (1) 1
Government Document (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2407) 2407
index medicus (1998) 1998
newly-diagnosed glioblastoma (1260) 1260
oncology (1203) 1203
female (1202) 1202
male (1175) 1175
adult (884) 884
clinical neurology (860) 860
middle aged (835) 835
aged (737) 737
glioblastoma (608) 608
cancer (539) 539
newly diagnosed (499) 499
newly-diagnosed epilepsy (486) 486
temozolomide (471) 471
chemotherapy (459) 459
radiotherapy (445) 445
treatment outcome (441) 441
care and treatment (412) 412
survival (395) 395
glioblastoma multiforme (392) 392
adolescent (385) 385
prognosis (375) 375
child (344) 344
analysis (340) 340
epilepsy (336) 336
adjuvant temozolomide (328) 328
medicine & public health (314) 314
neurology (294) 294
aged, 80 and over (293) 293
research (293) 293
brain neoplasms - drug therapy (292) 292
patients (285) 285
radiation-therapy (284) 284
animals (280) 280
bevacizumab (276) 276
hematology (273) 273
risk factors (267) 267
brain neoplasms - therapy (266) 266
malignant glioma (265) 265
anticonvulsants - therapeutic use (264) 264
pharmacology & pharmacy (263) 263
double-blind (262) 262
young adult (260) 260
children (257) 257
newly-diagnosed myeloma (255) 255
brain neoplasms - pathology (252) 252
retrospective studies (252) 252
surgery (249) 249
glioblastoma - drug therapy (247) 247
neurosciences (246) 246
phase-ii trial (245) 245
gliomas (240) 240
glioma (235) 235
health aspects (234) 234
multiple myeloma (234) 234
epilepsy - drug therapy (232) 232
drug therapy (227) 227
therapy (225) 225
glioblastoma - therapy (218) 218
dacarbazine - analogs & derivatives (216) 216
article (215) 215
trial (207) 207
diagnosis (206) 206
clinical trials (203) 203
antiepileptic drugs (201) 201
quality-of-life (197) 197
antineoplastic agents - therapeutic use (194) 194
multiforme (193) 193
glioblastoma - pathology (185) 185
high-grade gliomas (183) 183
quality of life (181) 181
recurrent glioblastoma (180) 180
carbamazepine (176) 176
tumors (176) 176
seizures (175) 175
combined modality therapy (173) 173
child, preschool (171) 171
brain tumors (170) 170
glioblastoma - mortality (170) 170
medical diagnosis (170) 170
stem-cell transplantation (170) 170
psychiatry (169) 169
medical research (168) 168
prevalence (168) 168
antineoplastic combined chemotherapy protocols - therapeutic use (167) 167
follow-up studies (166) 166
brain neoplasms - mortality (164) 164
phase-ii (164) 164
disease-free survival (161) 161
immunology (161) 161
clinical trials as topic (159) 159
radiology, nuclear medicine & medical imaging (157) 157
radiation (156) 156
dacarbazine - therapeutic use (154) 154
medicine, general & internal (150) 150
multiple myeloma - drug therapy (147) 147
newly-diagnosed patients (144) 144
survival analysis (144) 144
lamotrigine (143) 143
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (9) 9
UTL at Downsview - May be requested (4) 4
OISE - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Trinity College (John W Graham) - Storage (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3481) 3481
French (45) 45
German (33) 33
Spanish (17) 17
Chinese (10) 10
Russian (10) 10
Japanese (8) 8
Czech (6) 6
Korean (5) 5
Polish (4) 4
Hungarian (3) 3
Swedish (3) 3
Italian (2) 2
Portuguese (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Oncology, ISSN 1198-0052, 2017, Volume 24, Issue 5, pp. e361 - e367
Purpose We assessed response to treatment, toxicity, time to progression, progression-free survival, and overall survival in patients newly diagnosed with... 
Dexamethasone | Lenalidomide | Multiple myeloma | Newly diagnosed | dexamethasone | newly diagnosed | ONCOLOGY | ABNORMALITIES | PROGNOSIS | COMBINATION THERAPY | lenalidomide | THALIDOMIDE | Original | Multiple myeloma, newly diagnosed
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 07/2018, Volume 182, Issue 2, pp. 231 - 244
Summary Weekly ixazomib with lenalidomide‐dexamethasone (Rd) is feasible and has shown activity in newly diagnosed multiple myeloma (NDMM) patients. This phase... 
newly diagnosed | multiple myeloma | oral | ixazomib | twice‐weekly | twice-weekly | BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE | PROTEASOME INHIBITOR IXAZOMIB | CYCLOPHOSPHAMIDE | AUTOLOGOUS TRANSPLANTATION | OPEN-LABEL | MAINTENANCE THERAPY | CARFILZOMIB | CONSOLIDATION THERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | LOW-DOSE DEXAMETHASONE | Glycine - analogs & derivatives | Glycine - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Boron Compounds - administration & dosage | Dose-Response Relationship, Drug | Multiple Myeloma - drug therapy | Aged, 80 and over | Lenalidomide - pharmacokinetics | Adult | Female | Glycine - administration & dosage | Glycine - pharmacokinetics | Dexamethasone - administration & dosage | Drug Administration Schedule | Administration, Oral | Boron Compounds - pharmacokinetics | Treatment Outcome | Dexamethasone - pharmacokinetics | Disease-Free Survival | Lenalidomide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lenalidomide - adverse effects | Boron Compounds - adverse effects | Aged | Complications and side effects | Medical research | Care and treatment | Hyperglycemia | Dexamethasone | Multiple myeloma | Medicine, Experimental | Steroids | Toxicity | Pharmacology | Pharmacokinetics | Peripheral neuropathy | Patients | Drug dosages | Index Medicus | Haematological Malignancy | Research Paper
Journal Article
Journal Article